Influenza AB Combo Rapid Test Manufacturer: QL Biotech
Product Main Parameters
| Parameter | Details |
|---|---|
| Type | Rapid Test |
| Target Viruses | Influenza A and B |
| Sample Type | Nasopharyngeal Swab |
| Result Time | 15-30 minutes |
Common Product Specifications
| Specification | Details |
|---|---|
| Brand | QL Biotech |
| Certificate | CE |
| Pack | 25 Tests |
| Storage | 2-30℃ |
| Shelf Life | 2 years |
Product Manufacturing Process
The manufacturing process of the Influenza AB Combo Rapid Test involves several critical steps for ensuring accuracy and reliability. It begins with the precise formulation and application of specific antibodies onto test strips. Rigorous quality controls are implemented at each stage to ensure batch consistency. The process utilizes advanced membrane technology that enhances the capillary action required for sample migration. Notably, this method has been validated in peer-reviewed studies as a robust approach for rapid diagnostic devices. The use of high-quality materials and automated production lines further solidifies its reputation as a reliable product from QL Biotech.
Product Application Scenarios
The Influenza AB Combo Rapid Test is widely used in various healthcare settings, including hospitals, clinics, and emergency departments. It is particularly beneficial during the influenza season or in outbreak situations where rapid diagnosis is critical for managing patient care and preventing virus spread. Its point-of-care convenience allows for immediate testing and decision-making. Studies have highlighted its effectiveness in improving patient outcomes by enabling timely antiviral treatment initiation. This test supports public health efforts by providing data that can shape community health responses to influenza outbreaks.
Product After-Sales Service
QL Biotech provides comprehensive after-sales support for the Influenza AB Combo Rapid Test. This includes customer service assistance, product training, and troubleshooting guidance. Our dedicated support team ensures efficient handling of any inquiries or issues that may arise post-purchase.
Product Transportation
We ensure that the Influenza AB Combo Rapid Test is transported under optimal conditions to preserve its integrity. Packaging is designed to protect from environmental factors during transit, and we work with reliable logistics partners to ensure timely delivery.
Product Advantages
- Speed: Provides results within 15-30 minutes.
- Convenience: Easy-to-use at the point of care.
- Accessibility: Does not require specialized laboratory equipment.
Product FAQ
- What sample type is required? The test requires a nasopharyngeal swab from the patient.
- How long does it take to get results? Results are available typically within 15-30 minutes after sample collection.
- Is the test reliable? Yes, while slightly less sensitive than PCR, it is reliable for rapid diagnosis in point-of-care settings.
- How should the test be stored? The test should be stored at temperatures between 2-30℃.
- Can it detect both influenza A and B? Yes, the test can identify both influenza A and B viruses.
- Is the test approved for use? Yes, it comes with CE certification ensuring compliance with regulatory standards.
- What is the shelf life of the test? The shelf life of the test is 2 years when stored properly.
- What is the main advantage of the test? Its rapid result delivery, allowing prompt clinical decisions.
- Who can perform the test? It is intended for use by healthcare professionals.
- Are there any limitations? Sensitivity may be lower than PCR, and timing of testing can affect accuracy.
Product Hot Topics
- How does the manufacturer ensure test accuracy? QL Biotech employs rigorous quality control measures at every manufacturing stage to ensure the accuracy and reliability of the Influenza AB Combo Rapid Test. This includes using the highest quality antibodies and materials, validated through extensive research and testing.
- What makes the Influenza AB Combo Rapid Test stand out? The distinguishing feature of the Influenza AB Combo Rapid Test is its quick turnaround time and ease of use in point-of-care settings. Manufactured by QL Biotech, it supports efficient patient management and public health interventions during flu outbreaks.
- How is the test used in public health? As a tool for rapid diagnosis, the Influenza AB Combo Rapid Test aids public health officials in tracking and controlling influenza outbreaks. Its rapid results help in implementing timely and effective control measures.
- What training is provided? QL Biotech offers comprehensive training for healthcare professionals to ensure effective use of the Influenza AB Combo Rapid Test. This includes instructional materials and support from our customer service team.
- What should be considered when using the test? Proper sample collection and timing are crucial for accurate results. The manufacturer recommends adhering strictly to provided guidelines for optimal performance.
- How does the test contribute to patient care? By providing quick and reliable results, the Influenza AB Combo Rapid Test supports immediate clinical decisions, helping reduce the spread and impact of influenza.
- Is the test suitable for all healthcare settings? Yes, it is suitable for multiple healthcare settings, including hospitals, clinics, and potentially in community health centers.
- How does the manufacturer support innovation? QL Biotech continuously engages in research and development to enhance test performance and adapt to evolving healthcare needs.
- How are results read? Results are interpreted based on the presence of lines on the test strip; a control line must appear for a valid result.
- What are the environmental considerations? The test is designed to be effective across a range of environmental conditions, but it should be stored correctly to maintain accuracy and reliability.
Image Description
